NOF Partners with Farmacopea, Inc. to Conduct Health Education Outreach to Hispanic Audiences in the United States »

| Press Releases

ARLINGTON, VA (April 5, 2017) — The National Osteoporosis Foundation (NOF), the nation’s leading healthcare organization dedicated to bone health, announced today a new partnership with Farmacopea, Inc., an independent, minority-owned and women-owned agency that consults with clients on healthcare advertising and communications to target Spanish-speaking patients, caregivers and healthcare professionals. Together, NOF and Farmacopea… Read more »

Osteoporosis Care is Under Siege: How You Can Help »

| Advocacy

Fractures related to osteoporosis threaten the health and independence of older Americans. And fractures are common: more than 2 million fractures happen each year due to osteoporosis. The statistics are staggering and unnecessary. A DXA (Dual-energy X-ray absorptiometry) bone density test is a non-invasive, simple, yet top-quality test for screening and diagnosing patients that may… Read more »

Health Buzz: Meredith Vieira: ‘There’s No Excuse for Not Thinking About Bone Health’ »

| Osteoporosis in the News

Meredith Vieira, the popular journalist and talk-show host says “There’s no excuse for not knowing about bone health and being proactive with your doctor.” Vieira, 63, who’s teamed up with bonenews.com, is opening up about her connection to osteoporosis, which affects about 10 million Americans over age 50, and the link between fractures and postmenopausal… Read more »

The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay »

| Advocacy, BHOF in the News, Press Releases

Washington, DC (June 13, 2017) – The National Osteoporosis Foundation (NOF), today issued the following statement in response to the Senate HELP hearing “The Cost of Prescription Drugs: How the Drug Delivery System Affects What Patients Pay” “During today’s hearing, several Senators raised the idea of allowing for the government to set prices in the… Read more »

Osteoporosis: ACP update treatment guidelines for preventing bone fractures »

| BHOF in the News, Osteoporosis in the News

To reduce the risk of hip and vertebral fractures in women with osteoporosis, physicians should treat them with the bisphosphonates risedronate, alendronate, or zoledronic acid, or alternatively with the biologic agent denosumab. This strong recommendation appears in revised guidelines from the American College of Physicians (ACP) for the prevention of fractures in men and women… Read more »

NOF Response to the Newly Published “Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update from the American College of Physicians” (ACP) »

| Osteoporosis in the News

On Monday, May 8th, the American College of Physicians (ACP) released its updated guidelines for treatment of men and women with low bone density or osteoporosis. The National Osteoporosis Foundation (NOF) applauds the ACP for recognizing the need to update its previous guidelines from 2008 and emphasizing the importance of treatment for osteoporosis and the… Read more »

308 Health Advocates Urge Congress to Protect Patients & Oppose Government Intervention in Medicare Part D »

| Press Releases

Washington, DC (February 21, 2017) – Today, the National Osteoporosis Foundation (NOF) and over 307 national and state health organizations urged legislators to protect patient access to medications by opposing proposals to allow the Secretary of Health and Human Services (HHS) to interfere in the Medicare Part D program. Specifically, the letter advocates for preserving… Read more »